Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000625166 | SCV000602540 | benign | Autosomal dominant slowed nerve conduction velocity | 2023-11-22 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000625166 | SCV000743958 | benign | Autosomal dominant slowed nerve conduction velocity | 2014-10-09 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625166 | SCV000745418 | benign | Autosomal dominant slowed nerve conduction velocity | 2015-01-15 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002060166 | SCV002408868 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003915407 | SCV004729947 | benign | ARHGEF10-related condition | 2019-12-05 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV001706651 | SCV001918821 | benign | not specified | no assertion criteria provided | clinical testing |